Horst Vernon D, Patel Hetal D, Hewlett Stan C
Department of Surgery, Brookwood Baptist Health System, Birmingham, Alabama, USA.
Am Surg. 2016 Aug;82(8):730-2.
Esophageal cancer is an uncommon but highly lethal disease. Surgical resection is the gold standard of treatment for early-stage disease. Traditional surgical approach entailed significant convalescence, hospital stay, and morbidity and mortality. Transhiatal esophagectomy (THE) involves blind dissection of the esophagus with minimal mediastinal lymphadenectomy. Integration of robotic surgery is an alternate platform for minimally invasive approach while maintaining safety and following oncologic principles. We review our technique for minimally invasive THE using robotic technology, demonstrating the safety and efficacy of robotic technology surgery. We present a retrospective review of a single surgeon's data of patients treated with robotic-assisted THE, with a chart review to evaluate pathology, adequacy of surgical resection, nodal harvest, and perioperative course. Robotic THE (rTHE) shows promise as a valid option for esophageal resection, including premalignant and advanced stages of cancer. Adequate transhiatal mediastinal nodal resection can be performed with the robot.
食管癌是一种罕见但致死率很高的疾病。手术切除是早期疾病治疗的金标准。传统手术方法会导致较长的康复期、住院时间以及较高的发病率和死亡率。经裂孔食管切除术(THE)涉及对食管进行盲式解剖并进行最小限度的纵隔淋巴结清扫。机器人手术的整合是一种微创方法的替代平台,同时能保持安全性并遵循肿瘤学原则。我们回顾了使用机器人技术进行微创THE的技术,证明了机器人技术手术的安全性和有效性。我们对一位外科医生采用机器人辅助THE治疗的患者数据进行了回顾性分析,并通过图表回顾来评估病理情况、手术切除的充分性、淋巴结清扫情况以及围手术期过程。机器人经裂孔食管切除术(rTHE)显示出作为食管切除术有效选择的前景,包括癌前病变和癌症晚期阶段。使用机器人可以进行充分的经裂孔纵隔淋巴结清扫。